Fecal calprotectin cutoffs: indeterminate colitis vs CD

What is known

• Calprotectin correlates with endoscopic and histologic mucosal inflammation and is used to distinguish inflammatory from non-inflammatory GI conditions, not to subtype IBD. ^1–3
• Reported calprotectin sensitivity and specificity vary across studies depending on the chosen cutoff value. ^2,4
• Fecal markers differentiated IBD from other forms of colitis with only 43–50% overall accuracy. ⁵
• In one small pediatric series, indeterminate colitis cases had low calprotectin values, but the numbers were too few to define a distinguishing threshold. ³

What is unknown / caveats

• Excerpts address calprotectin for diagnosing IBD or detecting inflammation, not for separating IBD subtypes
• Cutoff performance varies by threshold and assay, and one study could not compute an optimal cutoff because values above 500 were not diluted
• Indeterminate-colitis data are limited to a few pediatric cases
• No retrieved study evaluated a calprotectin cutoff specifically to separate indeterminate colitis from Crohn's disease, so reliability for that use cannot be assessed.

References

1. Rosenfeld G, Greenup AJ, Round A, Takach O, Halparin L, Saadeddin A, Ho JK, Lee T, Enns R, Bressler B. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease. World J Gastroenterol. 2016;22(36):8211-8. PMID: 27688663.

2. Ho SSC, Ross M, Keenan JI, Day AS. Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children. Front Pediatr. 2020;8:609279. PMID: 33748035.

3. Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;33(1):14-22. PMID: 11479402.

4. Pivac I, Jelicic Kadic A, Despot R, Zitko V, Tudor D, Runjic E, Markic J. Characteristics of the Inflammatory Bowel Disease in Children: A Croatian Single-Centre Retrospective Study. Children (Basel). 2023;10(10). PMID: 37892340.

5. Turkay C, Kasapoglu B. Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics (Sao Paulo). 2010;65(2):221-31. PMID: 20186307.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.